Daniel Reed

870 total citations
45 papers, 551 citations indexed

About

Daniel Reed is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel Reed has authored 45 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel Reed's work include Advanced Radiotherapy Techniques (10 papers), Acute Lymphoblastic Leukemia research (10 papers) and Neutropenia and Cancer Infections (7 papers). Daniel Reed is often cited by papers focused on Advanced Radiotherapy Techniques (10 papers), Acute Lymphoblastic Leukemia research (10 papers) and Neutropenia and Cancer Infections (7 papers). Daniel Reed collaborates with scholars based in United States, Canada and France. Daniel Reed's co-authors include Kent E. Wallner, Gregory S. Merrick, Surabhi Palkimas, Tri Minh Le, Hillary S. Maitland, Christopher Biggs, Terry Lee, Suresh Rana, Eric Ford and Michael Keng and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Daniel Reed

42 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Reed United States 12 237 215 103 89 76 45 551
V. Bishay United States 11 276 1.2× 48 0.2× 193 1.9× 69 0.8× 35 0.5× 44 748
Ethan Prince United States 14 279 1.2× 62 0.3× 64 0.6× 59 0.7× 28 0.4× 31 670
Tai‐Lin Huang Taiwan 15 297 1.3× 80 0.4× 58 0.6× 37 0.4× 58 0.8× 50 752
Fred Verzijlbergen Netherlands 16 374 1.6× 53 0.2× 408 4.0× 106 1.2× 47 0.6× 29 854
Kenneth M. Algazy United States 8 432 1.8× 115 0.5× 193 1.9× 97 1.1× 26 0.3× 15 723
Mirosław Dziuk Poland 12 217 0.9× 87 0.4× 276 2.7× 57 0.6× 25 0.3× 52 433
Benoît Ghaye Belgium 15 282 1.2× 24 0.1× 179 1.7× 201 2.3× 18 0.2× 51 777
Steven Yevich United States 14 181 0.8× 28 0.1× 106 1.0× 25 0.3× 32 0.4× 53 661
JEFF A. WIEDER United States 12 754 3.2× 24 0.1× 77 0.7× 71 0.8× 109 1.4× 18 946
Peter Lin Australia 15 216 0.9× 40 0.2× 254 2.5× 31 0.3× 13 0.2× 46 540

Countries citing papers authored by Daniel Reed

Since Specialization
Citations

This map shows the geographic impact of Daniel Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Reed more than expected).

Fields of papers citing papers by Daniel Reed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Reed. The network helps show where Daniel Reed may publish in the future.

Co-authorship network of co-authors of Daniel Reed

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Reed. A scholar is included among the top collaborators of Daniel Reed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Reed. Daniel Reed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reed, Daniel, Scott Isom, Leslie R. Ellis, et al.. (2023). Real-world outcomes of adult patients with acute lymphoblastic leukemia treated with a modified CALGB 10102 regimen. Annals of Hematology. 102(4). 897–906.
3.
4.
Tooze, Janet A., Kathryn E. Callahan, Nicholas M. Pajewski, et al.. (2023). Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia. Journal of Geriatric Oncology. 14(7). 101509–101509. 5 indexed citations
5.
Reed, Daniel, et al.. (2022). Targeting Apoptosis in ALL. Current Hematologic Malignancy Reports. 17(2). 53–60. 3 indexed citations
6.
Reed, Daniel, Gina R. Petroni, Melissa West, et al.. (2021). Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation. Hematology/Oncology and Stem Cell Therapy. 16(1). 61–69. 5 indexed citations
7.
Isaac, Krista M., Daniel Reed, Eli S. Williams, et al.. (2021). Epidemiology of acute myeloid leukemia in Virginia: Excellent survival outcomes for patients in rural Appalachia. Cancer Reports. 4(4). e1354–e1354. 3 indexed citations
8.
Reed, Daniel, Bethany J. Horton, Margaret E. Moore, et al.. (2019). Immune-related adverse events in advanced NSCLC treated with immunotherapy alone or concurrent chemotherapy and immunotherapy.. Journal of Clinical Oncology. 37(8_suppl). 83–83. 2 indexed citations
9.
10.
Reed, Daniel, et al.. (2019). Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib. Clinical Lymphoma Myeloma & Leukemia. 19(6). e247–e250. 9 indexed citations
11.
Reed, Daniel, et al.. (2018). Venous Thromboembolism Events and Prophylaxis in Patients with Acute Myeloid Leukemia. Blood. 132(Supplement 1). 5066–5066. 1 indexed citations
12.
Reed, Daniel, et al.. (2018). Safety and effectiveness of apixaban compared to warfarin in dialysis patients. Research and Practice in Thrombosis and Haemostasis. 2(2). 291–298. 89 indexed citations
13.
Rana, Suresh, et al.. (2013). Verification and Dosimetric Impact of Acuros XB Algorithm for Stereotactic Body Radiation Therapy (SBRT) and RapidArc Planning for Non-Small-Cell Lung Cancer (NSCLC) Patients. International Journal of Medical Physics Clinical Engineering and Radiation Oncology. 2(1). 6–14. 32 indexed citations
14.
Dugan, William, et al.. (2010). A randomized placebo-controlled trial of daily high-dose oral risedronate in men with metastatic prostate cancer commencing androgen deprivation therapy (ADT).. Journal of Clinical Oncology. 28(15_suppl). e15000–e15000. 4 indexed citations
15.
Reed, Daniel, Kent E. Wallner, Gregory S. Merrick, et al.. (2007). A prospective randomized comparison of stranded vs. loose 125I seeds for prostate brachytherapy. Brachytherapy. 6(2). 129–134. 63 indexed citations
16.
Reed, Daniel, Kent E. Wallner, Sreeram Narayanan, et al.. (2005). Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients. International Journal of Radiation Oncology*Biology*Physics. 63(1). 301–307. 18 indexed citations
17.
Reed, Daniel, Skyler K. Lindsley, Gary N. Mann, et al.. (2005). Axillary lymph node dose with tangential breast irradiation. International Journal of Radiation Oncology*Biology*Physics. 61(2). 358–364. 65 indexed citations
18.
Reed, Daniel, Kent E. Wallner, Eric Ford, et al.. (2005). Effect of post-implant edema on prostate brachytherapy treatment margins. International Journal of Radiation Oncology*Biology*Physics. 63(5). 1469–1473. 25 indexed citations
19.
Wallner, Kent E., et al.. (2005). Extraprostatic Seed Placement and Its Effect on Seed Loss. The Cancer Journal. 11(2). 147–151. 8 indexed citations
20.
Wallner, Kent E., Gregory S. Merrick, William Cavanagh, et al.. (2004). The Prognostic Significance of Gleason Pattern 5 in Prostate Cancer Patients Treated with Pd 103 plus Beam Radiation Therapy. The Cancer Journal. 10(5). 301–306. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Bishay Breakdown of academic impact, for papers by Ethan Prince Breakdown of academic impact, for papers by Tai‐Lin Huang Breakdown of academic impact, for papers by Fred Verzijlbergen Breakdown of academic impact, for papers by Kenneth M. Algazy Breakdown of academic impact, for papers by Mirosław Dziuk Breakdown of academic impact, for papers by Benoît Ghaye Breakdown of academic impact, for papers by Steven Yevich Breakdown of academic impact, for papers by JEFF A. WIEDER Breakdown of academic impact, for papers by Peter Lin
Rankless by CCL
2026